National Resilience acquired the Triangle office in 2021. Since then, funding for gene therapy solutions has fallen.

In October 2023, a group that included Elliott Investment Management, Patient Square Capital and Veritas Capital acquired ...

Following a fresh round of job cuts in December, CDMO National Resilience is carrying its downsizing efforts into 2025. | ...

Enforcing environmental laws isn’t a job that makes people popular. But polls show that Americans generally want more environmental protection, not less.

Top business leaders in the region share what they're watching for growth opportunities in 2025 ... and reveal the pitfalls ...

ORLADEYO net revenue expected to be between $515-$535 million in 2025——Total revenue (including RAPIVAB®) expected to be between $540-$560 ...

How does geography fuel North Carolina expansion? Plus, the H-1B visa debate heats up, net neutrality is dealt a blow, and ...

ORLADEYO net revenue expected to be between $515-$535 million in 2025- -Total revenue (including RAPIVAB®) expected to be between $540-$560 million in 2025- -Company achieved operating profit in 2024 ...

Toshiba and Qualcomm are collaborating to bring advanced, scalable AI-powered IoT solutions to the retail industry.

National Reliance Inc., which focuses on biologics, vaccines, and gene therapies, is expected to keep the Triangle office open after the cuts.

Inverse associations are observed between fluoride measurements in urine and drinking water and children's IQ, according to a ...